These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 21685232)

  • 21. Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
    Waubant E; Mowry EM; Krupp L; Chitnis T; Yeh EA; Kuntz N; Ness J; Belman A; Milazzo M; Gorman M; Weinstock-Guttman B; Rodriguez M; James JA
    Mult Scler; 2013 Jun; 19(7):891-5. PubMed ID: 23232601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
    Levin LI; Munger KL; O'Reilly EJ; Falk KI; Ascherio A
    Ann Neurol; 2010 Jun; 67(6):824-30. PubMed ID: 20517945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low sun exposure acts synergistically with high Epstein-Barr nuclear antigen 1 (EBNA-1) antibody levels in multiple sclerosis etiology.
    Hedström AK; Huang J; Brenner N; Butt J; Kockum I; Waterboer T; Olsson T; Alfredsson L
    Eur J Neurol; 2021 Dec; 28(12):4146-4152. PubMed ID: 34435414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model.
    Jog NR; McClain MT; Heinlen LD; Gross T; Towner R; Guthridge JM; Axtell RC; Pardo G; Harley JB; James JA
    J Autoimmun; 2020 Jan; 106():102332. PubMed ID: 31515129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teriflunomide's effect on humoral response to Epstein-Barr virus and development of cortical gray matter pathology in multiple sclerosis.
    Zivadinov R; Ramanathan M; Hagemeier J; Bergsland N; Ramasamy DP; Durfee J; Kolb C; Weinstock-Guttman B
    Mult Scler Relat Disord; 2019 Nov; 36():101388. PubMed ID: 31525628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smoking and Epstein-Barr virus infection in multiple sclerosis development.
    Hedström AK; Huang J; Brenner N; Butt J; Hillert J; Waterboer T; Kockum I; Olsson T; Alfredsson L
    Sci Rep; 2020 Jul; 10(1):10960. PubMed ID: 32620875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk.
    Strautins K; Tschochner M; James I; Choo L; Dunn DS; Pedrini M; Kermode A; Carroll W; Nolan D
    Mult Scler; 2014 Mar; 20(3):286-94. PubMed ID: 23886832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EBNA-1 IgG titers in Sardinian multiple sclerosis patients and controls.
    Mameli G; Cossu D; Cocco E; Masala S; Frau J; Marrosu MG; Sechi LA
    J Neuroimmunol; 2013 Nov; 264(1-2):120-2. PubMed ID: 24099984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study.
    Sundström P; Juto P; Wadell G; Hallmans G; Svenningsson A; Nyström L; Dillner J; Forsgren L
    Neurology; 2004 Jun; 62(12):2277-82. PubMed ID: 15210894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk.
    Simon KC; van der Mei IA; Munger KL; Ponsonby A; Dickinson J; Dwyer T; Sundström P; Ascherio A
    Neurology; 2010 Apr; 74(17):1365-71. PubMed ID: 20375311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis.
    Wagner HJ; Hennig H; Jabs WJ; Siekhaus A; Wessel K; Wandinger KP
    Viral Immunol; 2000; 13(4):497-502. PubMed ID: 11192296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S; Kamata Y; Ishii Y; Eda H; Kitamura R; Obayashi M; Ito S; Ban F; Kuranari J; Nakajima H; Kuze T; Hayashi M; Okabe N; Senpuku H; Miyasaka N; Nakamura Y; Kanegane H; Yanagi K
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):123-30. PubMed ID: 14715558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr Virus and multiple sclerosis in a Spanish cohort: A two-years longitudinal study.
    Domínguez-Mozo MI; López-Lozano L; Pérez-Pérez S; García-Martínez Á; Torrejón MJ; Arroyo R; Álvarez-Lafuente R
    Front Immunol; 2022; 13():991662. PubMed ID: 36189297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
    Castellazzi M; Delbue S; Elia F; Gastaldi M; Franciotta D; Rizzo R; Bellini T; Bergamaschi R; Granieri E; Fainardi E
    Dis Markers; 2015; 2015():901312. PubMed ID: 26101453
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women.
    Goldstein BL; Chibnik LB; Karlson EW; Costenbader KH
    Autoimmunity; 2012 Mar; 45(2):161-8. PubMed ID: 22011088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Epstein-Barr virus-specific antibodies in Cypriot multiple sclerosis patients.
    Deeba E; Koptides D; Gaglia E; Constantinou A; Lambrianides A; Pantzaris M; Krashias G; Christodoulou C
    Mol Immunol; 2019 Jan; 105():270-275. PubMed ID: 30562647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus nuclear antigen-1 B-cell epitopes in multiple sclerosis twins.
    Mechelli R; Anderson J; Vittori D; Coarelli G; Annibali V; Cannoni S; Aloisi F; Salvetti M; James JA; Ristori G
    Mult Scler; 2011 Nov; 17(11):1290-4. PubMed ID: 21757535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
    Mouhieddine TH; Darwish H; Fawaz L; Yamout B; Tamim H; Khoury SJ
    Clin Immunol; 2015 May; 158(1):59-66. PubMed ID: 25805657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.